The dosing of ibrutinib and related Bruton’s tyrosine kinase inhibitors: eliminating the use of brute force

Detalles Bibliográficos
Autores principales: Ratain, Mark J., Tannock, Ian F., Lichter, Allen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631621/
https://www.ncbi.nlm.nih.gov/pubmed/35816636
http://dx.doi.org/10.1182/bloodadvances.2022007793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631621/
https://www.ncbi.nlm.nih.gov/pubmed/35816636
http://dx.doi.org/10.1182/bloodadvances.2022007793

Ejemplares similares